For many COVID-19 patients battling for their lives in the ICU, a runaway immune system response — known as a “cytokine storm” — is their primary foe. Doctors have few tools to help tame this hyperinflammatory condition, but early research is suggesting that nanotechnology might safely deliver drugs to affected tissues, quieting the storm.
